Science Explorer Back to mapMap
Discussion
Researcher · Thomas Jefferson University · United States

Emad S. Alnemri

Emad S. Alnemri publishes mostly in Molecular Biology, Immunology and Epidemiology, on topics such as Cell death mechanisms and regulation, Inflammasome and immune disorders and interferon and immune responses.

ORCID 0000-0002-7295-3383 OpenAlex
World rank
#8,617
of 7,710,434 ranked researchers
Rank in United States
#2,975
of 1,627,098
Works
228
Citations
72k
Citations per work
317.5
h-index
104
i10-index 173Top 0.2% in Molecular Biology
Emad S. Alnemri

What does Emad S. Alnemri research?

Emad S. Alnemri's work is mostly in Biochemistry, Genetics and Molecular Biology (58%), Immunology and Microbiology (14%), Medicine (10%).

Life Sciences: 164 works · 72.1% of their workBiochemistry, Genetics and Molecular Biology: 133 works · 58.2% of their workMolecular Biology: 118 works · 51.9% of their workCancer Research: 8 works · 3.5% of their workGenetics: 6 works · 2.8% of their workImmunology and Microbiology: 32 works · 13.9% of their workImmunology: 32 works · 13.9% of their workEverything else: 42 works · 18.4% of their workHealth Sciences: 22 works · 9.5% of their workMedicine: 22 works · 9.5% of their workEpidemiology: 13 works · 5.5% of their workOncology: 9 works · 4.0% of their workTHEIR WORKEmad S. Alnemri228works
Life Sciences72%Health Sciences10%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology13358.2%
    2. Immunology and Microbiology3213.9%
  2. Everything else4218.4%
    1. Medicine229.5%
  1. 1Molecular Biology52% of their works
  2. 2Immunology14% of their works
  3. 3Epidemiology6% of their works
  4. 4Oncology4% of their works
  5. 5Cancer Research4% of their works
  6. 6Genetics3% of their works

Research topics

Which keywords describe Emad S. Alnemri's research?

The keywords of their largest research topics: Cell Death, Mitochondria, Apoptosis, Reactive Oxygen Species, Bcl-2 Family, Inflammation, TNF Signaling and Cancer.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 24 words, with their numbers
  1. Cell Death1563 topics
  2. Mitochondria1563 topics
  3. Apoptosis1222 topics
  4. Reactive Oxygen Species1142 topics
  5. Bcl-2 Family981 topic
  6. Inflammation984 topics
  7. TNF Signaling981 topic
  8. Cancer422 topics
  9. Immunity422 topics
  10. Inflammasome421 topic
  11. NLRP3421 topic
  12. Pattern Recognition Receptors402 topics
  13. Innate Immunity261 topic
  14. Viral Infection261 topic
  15. Autophagy241 topic
  16. Disease241 topic
  17. NF-?B181 topic
  18. Signaling181 topic
  19. Mitochondrial Dysfunction161 topic
  20. Oxidative Stress161 topic
  21. RNA Interference161 topic
  22. siRNA Delivery161 topic
  23. Innate Antiviral Responses141 topic
  24. Toll-like Receptors141 topic

Where does Emad S. Alnemri work?

Emad S. Alnemri's main affiliation in the publication record is Thomas Jefferson University, United States.

How many publications and citations does Emad S. Alnemri have?

OpenAlex counts 228 works and 72,396 citations for Emad S. Alnemri, an h-index of 104, ranking #8,617 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Emad S. Alnemri. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.